AG
RARX

Algert Global’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Algert Global’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,880
Closed -$328K – 469
2019
Q3 		$328K Sell
13,880
-8,490
-38% -$252K 0.12% 209
2019
Q2 		$673K Sell
22,370
-67
-0.3% -$1.53K 0.25% 132
2019
Q1 		$503K Sell
22,437
-37,340
-62% -$803K 0.29% 129
2018
Q4 		$1.09M Sell
59,777
-17,260
-22% -$271K 0.3% 114
2018
Q3 		$1.39M Buy
+77,037
New +$913K 0.3% 125

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Algert Global's RARX Position: Q4 2019 in Review

Algert Global sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 13,880 shares — an estimated $328K sold.

Algert Global first reported a position in RARX in Q3 2018 and held it in 5 quarters. The position peaked at $1.39M in Q3 2018. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • Algert Global reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Algert Global sold 13,880 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $328K.
  • Algert Global first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Algert Global's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.39M in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Algert Global's 13F filing for Q4 2019, filed 18 Feb 2020.